Published in

Wiley, Cochrane Library, 2015

DOI: 10.1002/14651858.cd011611.pub2

Cochrane Collaboration, Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858.cd011611

Informa Healthcare, Issues in Mental Health Nursing, 6(38), p. 526-527

DOI: 10.1080/01612840.2017.1322427

Links

Tools

Export citation

Search in Google Scholar

Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults

Journal article published in 2015 by Tayla L. McCloud, Kim van Wissen, Caroline Caddy, Jennifer M. Rendell, Janina Jochim, Claire Shuttleworth, Peter R. Diamond, Daniel Brett, Ben H. Amit, Layla Hamadi ORCID, Rupert McShane, Keith Hawton, Denise Blanchard, Andrea Cipriani
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

There is emerging evidence that glutamatergic system dysfunction might play an important role in the pathophysiology of bipolar depression. This review focuses on the use of glutamate receptor modulators for depression in bipolar disorder.